Medical research

For mitochondria, bigger may not be better

Goldilocks was on to something when she preferred everything "just right." Harvard Medical School researchers have found that when it comes to the length of mitochondria, the power-producing organelles, applying the fairy ...

Alzheimer's disease & dementia

Blocking the effects of amyloid b in Alzheimer's disease

During Alzheimer's disease, 'plaques' of amyloid beta (Ab) and tau protein 'tangles' develop in the brain, leading to the death of brain cells and disruption of chemical signaling between neurons. This leads to loss of memory, ...

Neuroscience

Clinical decline in Alzheimer's requires plaque and proteins

According to a new study, the neuron-killing pathology of Alzheimer's disease (AD), which begins before clinical symptoms appear, requires the presence of both amyloid-beta (a-beta) plaque deposits and elevated levels of ...

Alzheimer's disease & dementia

Cancer drug improves memory in mouse model of Alzheimer's disease

A compound that previously progressed to Phase II clinical trials for cancer treatment slows neurological damage and improves brain function in an animal model of Alzheimer's disease, according to a study in the March 14 ...

Neuroscience

Alzheimer's: French scientists focus on key target

French scientists said on Tuesday that lack of a key brain protein was linked to Alzheimer's, a finding that threw up a tempting target for drugs to fight the disease.

Alzheimer's disease & dementia

Alzheimer's vaccine cures memory of mice

(Medical Xpress) -- A vaccine that slows the progression of Alzheimer's disease and other types of dementia has been developed by researchers at the University of Sydney's Brain and Mind Research Institute (BMRI).

page 39 from 40